Aesyntix Health offers web-based reimbursement solution for dermatology industry

NewsGuard 100/100 Score

Aesyntix Health, Inc., a leading provider of solutions for dermatologists, today announced it will be offering the first-ever payer benchmarking for the Dermatology industry. Using real-time reimbursement data from hundreds of dermatologists across the United States, practices will be able to benchmark reimbursement performance against aggregate reimbursement data. With unprecedented levels of reporting, dermatologists will be able to compare reimbursement trends, denial patterns, and other key revenue life cycle metrics to make important changes that impact both reimbursement efficiency and payer negotiations.

“The addition of custom payer benchmarks is ground-breaking in the dermatology industry. It gives our customers much needed insight into payer reimbursement trends and keeps them ahead of the curve of reimbursement pitfalls.”

Through Aesyntix PaidRight™, a web-based reimbursement solution powered by RemitDATA, dermatologists are able to reduce denials, decrease the cost of collections, and improve reimbursement efficiencies. Aesyntix is offering custom payer benchmark metrics as a value-added service to help dermatology practices gain greater visibility into their practices’ reimbursement performance compared to their peers.

“Aesyntix Health is focused on solutions that bring great value to dermatologists by improving billing efficiency and reducing practice costs,” said Clark Avery, CEO of Aesyntix Health. “The addition of custom payer benchmarks is ground-breaking in the dermatology industry. It gives our customers much needed insight into payer reimbursement trends and keeps them ahead of the curve of reimbursement pitfalls.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New murine model sheds light on anti-MDA5 antibody-positive dermatomyositis